IS2628B - Lausn til inntöku sem inniheldur galantamín og sætumiðil - Google Patents

Lausn til inntöku sem inniheldur galantamín og sætumiðil

Info

Publication number: IS2628B
Authority: IS; Iceland
Prior art keywords: sweetener; solution containing; oral solution; containing galantamine; galantamine
Prior art date: 1999-10-26

Application number

IS6291A

Other languages

English (en)

Other versions

IS6291A (is

Inventor

Marc Karel Jozef Francois

Tony Mathilde J Kempen

Eddy A Josee De Proost

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-26

Filing date

2002-02-28

Publication date

2010-05-15

2002-02-28 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2002-02-28 Publication of IS6291A publication Critical patent/IS6291A/is

2010-05-15 Publication of IS2628B publication Critical patent/IS2628B/is

Links

ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title 2
235000003599 food sweetener Nutrition 0.000 title 1
229960003980 galantamine Drugs 0.000 title 1
ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 title 1
229940100688 oral solution Drugs 0.000 title 1
239000003765 sweetening agent Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Addiction (AREA)
Psychology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

IS6291A 1999-10-26 2002-02-28 Lausn til inntöku sem inniheldur galantamín og sætumiðil IS2628B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99203512		1999-10-26
PCT/EP2000/010203 WO2001030318A1 (en)	1999-10-26	2000-10-16	Oral solution containing galanthamine and a sweetening agent

Publications (2)

Publication Number	Publication Date
IS6291A IS6291A (is)	2002-02-28
IS2628B true IS2628B (is)	2010-05-15

Family

ID=8240778

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6291A IS2628B (is)	1999-10-26	2002-02-28	Lausn til inntöku sem inniheldur galantamín og sætumiðil

Country Status (29)

Country	Link
EP (1)	EP1237539B1 (is)
JP (1)	JP2003512415A (is)
KR (1)	KR100502391B1 (is)
CN (1)	CN1200691C (is)
AR (1)	AR026243A1 (is)
AT (1)	ATE306904T1 (is)
AU (1)	AU780826C (is)
BG (1)	BG65792B1 (is)
BR (1)	BR0015025A (is)
CA (1)	CA2388830C (is)
CZ (1)	CZ301996B6 (is)
DE (1)	DE60023341T2 (is)
DK (1)	DK1237539T3 (is)
EA (1)	EA005683B1 (is)
EE (1)	EE05230B1 (is)
ES (1)	ES2250211T3 (is)
HR (1)	HRP20020332B1 (is)
HU (1)	HUP0203484A3 (is)
IL (2)	IL149310A0 (is)
IS (1)	IS2628B (is)
MX (1)	MXPA02004149A (is)
NO (1)	NO332096B1 (is)
PL (1)	PL201694B1 (is)
SI (1)	SI1237539T1 (is)
SK (1)	SK285643B6 (is)
TW (1)	TW592725B (is)
UA (1)	UA76095C2 (is)
WO (1)	WO2001030318A1 (is)
ZA (1)	ZA200203313B (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030162770A1 (en) *	2002-02-22	2003-08-28	Davis Bonnie M.	Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
WO2005016327A2 (en) *	2003-08-13	2005-02-24	Janssen Pharmaceutica, N.V.	Treatment of sleep disorders with cholinesterase inhibitors
CA2551946A1 (en) *	2003-12-31	2005-07-21	Actavis Group Hf	Immediate, controlled and sustained release formulations of galantamine
US8709521B2 (en) *	2007-05-22	2014-04-29	The Coca-Cola Company	Sweetener compositions having enhanced sweetness and improved temporal and/or flavor profiles
JP6348283B2 (ja) *	2011-01-27	2018-06-27	ニューレンファーマシューティカルズリミテッド	グリシル−ｌ−２−メチルプロリル−ｌ−グルタミン酸を用いる自閉症スペクトラム障害の治療
US20140107130A1 (en) *	2012-10-11	2014-04-17	Antrim Pharmaceuticals, LLC	Oral Solution Formulations of Aripiprazole
JP6457582B2 (ja) *	2017-04-14	2019-01-23	エルメッドエーザイ株式会社	ガランタミン含有医薬組成物、並びに医薬組成物におけるガランタミンの苦味抑制方法、及びガランタミンの苦味抑制剤
CN117717558A (zh) *	2023-12-06	2024-03-19	艾威药业(珠海)有限公司	加兰他敏及其药学上可接受的盐在制备治疗眼部疾病的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4010079A1 (de) *	1990-03-29	1991-10-02	Lohmann Therapie Syst Lts	Pharmazeutische formulierung zur behandlung des alkoholismus
US5272137A (en) *	1992-02-14	1993-12-21	Mcneil-Pfc, Inc.	Aqueous pharmaceutical suspension for pharmaceutical actives
US6323195B1 (en) *	1993-10-15	2001-11-27	Aventis Pharmaceuticals Inc.	Galanthamine derivatives as acetylcholinesterase inhibitors
JPH10273435A (ja) *	1997-01-29	1998-10-13	Fujisawa Pharmaceut Co Ltd	内服用液剤

2000
- 2000-10-16 UA UA2002054064A patent/UA76095C2/uk unknown
- 2000-10-16 EP EP00975872A patent/EP1237539B1/en not_active Expired - Lifetime
- 2000-10-16 CN CNB008147388A patent/CN1200691C/zh not_active Expired - Lifetime
- 2000-10-16 DE DE60023341T patent/DE60023341T2/de not_active Expired - Lifetime
- 2000-10-16 WO PCT/EP2000/010203 patent/WO2001030318A1/en not_active Ceased
- 2000-10-16 HR HR20020332A patent/HRP20020332B1/xx not_active IP Right Cessation
- 2000-10-16 DK DK00975872T patent/DK1237539T3/da active
- 2000-10-16 EA EA200200486A patent/EA005683B1/ru not_active IP Right Cessation
- 2000-10-16 HU HU0203484A patent/HUP0203484A3/hu unknown
- 2000-10-16 TW TW089121526A patent/TW592725B/zh not_active IP Right Cessation
- 2000-10-16 JP JP2001532738A patent/JP2003512415A/ja active Pending
- 2000-10-16 KR KR10-2002-7003258A patent/KR100502391B1/ko not_active Expired - Lifetime
- 2000-10-16 AT AT00975872T patent/ATE306904T1/de active
- 2000-10-16 EE EEP200200213A patent/EE05230B1/xx unknown
- 2000-10-16 AU AU13849/01A patent/AU780826C/en not_active Expired
- 2000-10-16 IL IL14931000A patent/IL149310A0/xx active IP Right Grant
- 2000-10-16 SI SI200030782T patent/SI1237539T1/sl unknown
- 2000-10-16 SK SK530-2002A patent/SK285643B6/sk not_active IP Right Cessation
- 2000-10-16 PL PL362849A patent/PL201694B1/pl unknown
- 2000-10-16 CA CA002388830A patent/CA2388830C/en not_active Expired - Lifetime
- 2000-10-16 CZ CZ20021329A patent/CZ301996B6/cs not_active IP Right Cessation
- 2000-10-16 MX MXPA02004149A patent/MXPA02004149A/es active IP Right Grant
- 2000-10-16 BR BR0015025-8A patent/BR0015025A/pt not_active Application Discontinuation
- 2000-10-16 ES ES00975872T patent/ES2250211T3/es not_active Expired - Lifetime
- 2000-10-25 AR ARP000105621A patent/AR026243A1/es not_active Application Discontinuation
2002
- 2002-02-28 IS IS6291A patent/IS2628B/is unknown
- 2002-03-20 BG BG106534A patent/BG65792B1/bg unknown
- 2002-04-24 IL IL149310A patent/IL149310A/en unknown
- 2002-04-25 ZA ZA200203313A patent/ZA200203313B/xx unknown
- 2002-04-26 NO NO20022003A patent/NO332096B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU780826B2 (en)	2005-04-21
SK285643B6 (sk)	2007-05-03
BR0015025A (pt)	2002-06-18
EP1237539A1 (en)	2002-09-11
CZ301996B6 (cs)	2010-09-01
PL362849A1 (en)	2004-11-02
ZA200203313B (en)	2003-11-26
ES2250211T3 (es)	2006-04-16
MXPA02004149A (es)	2002-10-17
AR026243A1 (es)	2003-02-05
HRP20020332B1 (hr)	2011-02-28
HRP20020332A2 (en)	2004-02-29
HUP0203484A2 (hu)	2003-02-28
CA2388830C (en)	2006-09-19
BG65792B1 (bg)	2009-12-31
IL149310A0 (en)	2002-11-10
EA005683B1 (ru)	2005-04-28
DE60023341T2 (de)	2006-07-27
HUP0203484A3 (en)	2004-12-28
BG106534A (en)	2002-12-29
JP2003512415A (ja)	2003-04-02
EA200200486A1 (ru)	2002-10-31
PL201694B1 (pl)	2009-04-30
HK1049619A1 (en)	2003-05-23
WO2001030318A1 (en)	2001-05-03
IS6291A (is)	2002-02-28
ATE306904T1 (de)	2005-11-15
SI1237539T1 (sl)	2006-04-30
UA76095C2 (en)	2006-07-17
DE60023341D1 (de)	2006-03-02
DK1237539T3 (da)	2006-02-27
NO20022003L (no)	2002-06-18
IL149310A (en)	2006-12-10
NO332096B1 (no)	2012-06-18
CZ20021329A3 (cs)	2002-08-14
CA2388830A1 (en)	2001-05-03
AU780826C (en)	2006-02-16
TW592725B (en)	2004-06-21
EP1237539B1 (en)	2005-10-19
EE05230B1 (et)	2009-12-15
SK5302002A3 (en)	2002-10-08
CN1200691C (zh)	2005-05-11
CN1382037A (zh)	2002-11-27
EE200200213A (et)	2003-06-16
AU1384901A (en)	2001-05-08
KR20020026010A (ko)	2002-04-04
KR100502391B1 (ko)	2005-07-19
NO20022003D0 (no)	2002-04-26

Publication	Publication Date	Title
DK1329456T3 (da)	2006-12-04	Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
IS6263A (is)	2002-02-08	Lyfjasamsetningar, sem innihalda trípeptíð
IS6264A (is)	2002-02-11	Arýlmetýl-karbónýlamínó-þíósól afleiður og notkunþeirra sem miðla gegn æxlum
PT1067905E (pt)	2003-02-28	Formulacoes efervescentes
DK1353919T3 (da)	2006-11-20	Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
IS6304A (is)	2002-03-18	Kínasólínefnasambönd og lyfjafræðilegar efnasamsetningar sem innihalda þau
HUP0203204A3 (en)	2004-06-28	Oral dosage forms
DK1454907T3 (da)	2009-03-09	Quninazolin og pyridopyrmidin-derivativer
DK1335678T3 (da)	2009-02-09	Oralt behandlingssystem
IS7304A (is)	2004-06-10	Tvívetnissetin pýrasólýlbensýlsúlfónamíð og lyf sem innihalda téð efnasambönd
ATE257159T1 (de)	2004-01-15	Oral wirksame androgene
ITMI982222A0 (it)	1998-10-16	Composizioni farmaceutiche orali contenenti buprenorfina
DK1057813T3 (da)	2004-08-16	Indolderivater og medicinske sammensætninger indeholdende de samme
IS2628B (is)	2010-05-15	Lausn til inntöku sem inniheldur galantamín og sætumiðil
ATE246502T1 (de)	2003-08-15	Arzneiformen enthaltend carvedilol
ID30397A (id)	2001-11-29	Larutan oral prukaloprida
NO20005722D0 (no)	2000-11-13	Brusetilberedninger
IS6734A (is)	2003-02-28	Tríasólafleiður og lyfjasamsetningar sem innihalda þær
GB9919574D0 (en)	1999-10-20	Dental floss devices
ITMI991641A0 (it)	1999-07-26	Dispositivo per impianto dentale
NO20014853D0 (no)	2001-10-05	Smakstilsetning
DK1043026T3 (da)	2005-07-04	Melanombehandling
IT248034Y1 (it)	2002-12-09	Nastro interdentale
DK1112262T3 (da)	2004-12-13	Substituerede gamma-delta-lactamer og analoger deraf og anvendelser relateret dertil
GB9901381D0 (en)	1999-03-10	Dental aid